93 related articles for article (PubMed ID: 8800057)
41. Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous carcinoma of the head and neck.
Pradier O; Christiansen H; Schmidberger H; Martin A; Jäckel MC; Steiner W; Ambrosch P; Kahler E; Hess CF
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1368-77. PubMed ID: 16169679
[TBL] [Abstract][Full Text] [Related]
42. Prognostic significance of serum squamous cell carcinoma antigen in patients with head and neck cancer.
Imai R; Takenaka Y; Yasui T; Nakahara S; Yamamoto Y; Hanamoto A; Takemoto N; Fukusumi T; Cho H; Yamamoto M; Inohara H
Acta Otolaryngol; 2015 Mar; 135(3):295-301. PubMed ID: 25622661
[TBL] [Abstract][Full Text] [Related]
43. Serum ferritin as a tumor marker in patients with squamous cell carcinoma of the head and neck.
Maxim PE; Veltri RW
Cancer; 1986 Jan; 57(2):305-11. PubMed ID: 3942962
[TBL] [Abstract][Full Text] [Related]
44. [Clinical value of head and neck tumor markers].
Gascón Vilaplana P
Med Clin (Barc); 2007 Dec; 129(20):775-6. PubMed ID: 18093479
[No Abstract] [Full Text] [Related]
45. The effects of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium.
Dabrow MB; Francesco MR; McBrearty FX; Caradonna S
Gynecol Oncol; 1998 Oct; 71(1):29-37. PubMed ID: 9784315
[TBL] [Abstract][Full Text] [Related]
46. Expression in lung carcinomas of platelet-derived growth factor and its receptors.
Kawai T; Hiroi S; Torikata C
Lab Invest; 1997 Nov; 77(5):431-6. PubMed ID: 9389786
[TBL] [Abstract][Full Text] [Related]
47. Serum insulin-like growth factor-I and platelet-derived growth factor as biomarkers of breast cancer prognosis.
Pasanisi P; Venturelli E; Morelli D; Fontana L; Secreto G; Berrino F
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1719-22. PubMed ID: 18628423
[TBL] [Abstract][Full Text] [Related]
48. [CEA studies in squamous cell carcinomas of the head and neck].
Schröder M; Meyer T
HNO; 1986 Aug; 34(8):334-42. PubMed ID: 3759515
[TBL] [Abstract][Full Text] [Related]
49. CYFRA 8/18 in head and neck cancer.
Maass JD; Niemann AM; Lippert BM; Gottschlich S; Folz BJ; Werner JA
Anticancer Res; 1999; 19(4A):2699-701. PubMed ID: 10470223
[TBL] [Abstract][Full Text] [Related]
50. Elevated levels of circulating endothelial progenitor cells in head and neck cancer patients.
Brunner M; Thurnher D; Heiduschka G; Grasl MCh; Brostjan C; Erovic BM
J Surg Oncol; 2008 Dec; 98(7):545-50. PubMed ID: 18792958
[TBL] [Abstract][Full Text] [Related]
51. Can Head and Neck Cancers Be Detected with Mean Platelet Volume?
Eryilmaz A; Basal Y; Omurlu IK
Asian Pac J Cancer Prev; 2015; 16(16):7045-7. PubMed ID: 26514488
[TBL] [Abstract][Full Text] [Related]
52. A prospective study of one-carbon metabolism biomarkers and cancer of the head and neck and esophagus.
Fanidi A; Relton C; Ueland PM; Midttun Ø; Vollset SE; Travis RC; Trichopoulou A; Lagiou P; Trichopoulos D; Bueno-de-Mesquita HB; Ros M; Boeing H; Tumino R; Panico S; Palli D; Sieri S; Vineis P; Sánchez MJ; Huerta JM; Barricarte Gurrea A; Luján-Barroso L; Quirós JR; Tjønneland A; Halkjær J; Boutron-Ruault MC; Clavel-Chapelon F; Cadeau C; Weiderpass E; Johansson M; Riboli E; Brennan P; Johansson M
Int J Cancer; 2015 Feb; 136(4):915-27. PubMed ID: 24975698
[TBL] [Abstract][Full Text] [Related]
53. Serum selenium levels in patients with head and neck cancer.
Yadav SP; Gera A; Singh I; Chanda R
J Otolaryngol; 2002 Aug; 31(4):216-9. PubMed ID: 12240756
[TBL] [Abstract][Full Text] [Related]
54. Investigation of urinary transforming growth factor alpha levels as tumor markers in patients with advanced squamous cell carcinoma of the head and neck.
Fazekas-May M; Suen JY; Yeh YC; Yeh HW; Milligan LB
Head Neck; 1990; 12(5):411-6. PubMed ID: 2211102
[TBL] [Abstract][Full Text] [Related]
55. Crystallization test for the detection of head and neck cancer.
Gulati SP; Sachdeva OP; Sachdeva A; Adlakha RP; Kakkar V
ORL J Otorhinolaryngol Relat Spec; 1994; 56(5):283-6. PubMed ID: 7970613
[TBL] [Abstract][Full Text] [Related]
56. Assessment of p38α in peripheral blood mononuclear cells (PBMC): a potential blood protein marker of head and neck squamous cell carcinoma.
Gill K; Kumar R; Mohanti BK; Dey S
Clin Transl Oncol; 2013 Nov; 15(11):969-73. PubMed ID: 23553334
[TBL] [Abstract][Full Text] [Related]
57. Platelet-derived growth factor (PDGF) in patients with different degrees of chronic arterial obstructive disease.
Cimminiello C; Arpaia G; Aloisio M; Uberti T; Rossi F; Pozzi F; Bonfardeci G
Angiology; 1994 Apr; 45(4):289-93. PubMed ID: 8161007
[TBL] [Abstract][Full Text] [Related]
58. Immunoassay of platelet-derived growth factor in the blood of patients with diabetes mellitus.
Harrison AA; Dunbar PR; Neale TJ
Diabetologia; 1994 Nov; 37(11):1142-6. PubMed ID: 7867886
[TBL] [Abstract][Full Text] [Related]
59. Zinc and copper levels in whole blood and plasma from patients with squamous cell carcinomas of head and neck.
Abdulla M; Biörklund A; Mathur A; Wallenius K
J Surg Oncol; 1979; 12(2):107-13. PubMed ID: 491677
[TBL] [Abstract][Full Text] [Related]
60. Prognostic significance of plasma prostaglandin E concentration in patients with head and neck cancer.
Klapan I; Katić V; Culo F; Cuk V
J Cancer Res Clin Oncol; 1992; 118(4):308-13. PubMed ID: 1577849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
